chrisvoncsefalvay/vaers-outcomes huggingface dataset:
fever; my lighter weight facial fillers swelled and were painful (around the eyes - not my lip fillers); my lighter weight facial fillers swelled and were painful (around the eyes - not my lip fillers); numbness in both hands; This is a spontaneous report from a contactable pharmacist (patient).  A 50-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EK4176, expiration date not reported), intramuscular on the left arm, on 07Jan2021, at 11:30 at a single dose for Covid-19 immunization. The patient has no medical history and no known allergies . There were no concomitant medications. The patient previously took the first vaccine of bnt162b2 on 18Dec2020, at 12:00 PM, Intramuscular, on the Right arm for Covid-19 immunization, he had numbness in his right hand x2 days. On 09Jan2021, following second dose, he has had numbness in both hands x2 days and on 10Jan2021, day 2, he ran a fever and his lighter weight facial fillers swelled and were painful (around the eyes - not my lip fillers). His eyes have a mix of Juvaderm products. It spontaneously resolved after 1 day with a subjective loss in overall volume. Density of the product used seemed to be a factor in the response. He knows this has been reported with the Moderna product, but he does not believe is has been reported with our product. It appears the response may not be product specific, but more specific to the type of vaccine. The patient has no Covid prior vaccination and not covid tested post vaccination. No treatment was received for the events. Outcome of the events was recovered in Jan2020.
vaccine administered at 2:36 PM, at 2:43 PM complained of burning sensation on the right side of her head. BP 120/60. at 2:55PM c/o increased flushing feeling, Benadryl 50 mg PO liquid given, and 1o mg cetirizine given PO. BP-90/58. at 2:58 PM c/o feeling worse, Epipen administered, rapid response called, ambulance contacted. at 3:01 BP 120/50 . transported to hospital.
PAROXYSMAL PALPATATIONS WORSENING WHEN LAYING DOWN (LASTING APPROX. 7 MONTHS), MODERATE TO SEVERE DRY COUGH (LASTING APPROX. 7 MONTHS), INTERMITTENT PAROXYSMAL SHORTNESS OF BREATH (LASTING APPROX. 7 MONTHS); NUMBNESS IN BOTH HANDS (HAS NOT ABBATED); TENDERNESS OF SACRUM (HAS NOT ABBATED);  SEVERE FATIGUE BEYOND PRE-EXISTING LEVELS.
Patient felt lightheaded upon standing when her observation period was over.  She also may have stood up too quickly, per pt.  She reports a low BP in general.  A bottle of water was given to patient; after drinking, she felt better. Her BP was 112/90.  Her HR was 68.  Patient reassured and felt better.  She was given another bottle of water and walked around a bit with no symptoms.  Patient left stable.
2 weeks after vaccines given - muscular weakness, distal hypertonicity of limbs, suspected tetanus. The patient presents with bilateral, lower extremity, altered gait and altered coordination. The onset was 1 weeks ago. The course/duration of symptoms is constant and worsening. The character of symptoms is weakness, off-balance and increased muscle tone/contracture. The degree at present is moderate. Risk factors consist of none. Prior episodes: none. Therapy today: none. Associated symptoms: none. Baseline status: ambulatory. Patient sent to the ED by PCP after evaluating patient this AM and then speaking with pediatric neurologist Dr. Patient presents with gait abnormality, LE stiffness for approximately 1-2 weeks, which has gotten progressively worse. Parents noted that they thought they observed abnormalities last week, but weren't fully aware of the situation until they received a call from patient's teacher who had observed his altered gait on the playground at school. Parents stated that patient was able to engage in physical activity throughout the week, but they grew particularly concerned yesterday. After a physically active day at a farm yesterday, patient was unable to walk after his evening bath, and was observed crawling/dragging his body. Patient is not in any pain, and does not note any discomfort. When asked where he feels weak, he points to his achilles tendon. Mom also notes that she has heard an occasional cough, which patient states his sister gave to him. Mom states that patient is up to date on his vaccinations, where he received his 3 shots at the end of September.
Episodes preceded by the injection site becoming extremely tender ,, swollen and turning multiple colors Tingling behinning in feet moving up through abdomen then head leaving me dizzy...not in touch with my body followed by profuse sweating.  On one occasion I was sweating on the left side of my body and nothing on the right side as if a line had been made down the middle of my face and body.  This followed by intense shaking.  No treatment.  Episodes continue sporadically.
Patient presented to the ED and was subsequently hospitalized for Atrial fibrillation with RVR within 6 weeks of receiving COVID vaccination.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34-year-old male patient received BNT162b2 (BNT162B2), on 24Jun2022 at 10:30 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 33 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose  1, single (Batch/Lot number: unknown), as dose  2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Multiple Sclerosis" (unspecified if ongoing); "Crohns" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment".  clinical source: Resurgence of symptoms. No known allergies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Approximately 5 months after my 3rd dose vaccination, I contracted COVID-19 and had the following symptoms: Runny nose and a slight cough. I did not take anything for treatment and just let my symptoms run its course. I consulted with my doctor and she said my symptoms weren't that bad and if it were to go worse I would have a session of the Monoclonal Antibody Infusion but thankfully it did not lead to that. Overall the symptoms lasted for about 6 days and as of today 06/09/2022 I have fully recovered.
Left arm started to be painful x 2 days, mostly deltoid area into left shoulder joint. Heat is helpful, worse in the AM. Left deltoid; no pain on palpation, no rash, no swelling.
had the typical left arm soreness for about a day or two and then nothing; had muscle stiffness and soreness that was around his buttocks and his thighs; had muscle stiffness and soreness that was around his buttocks and his thighs; felt "soreness for a few days afterward; This is a spontaneous report from a contactable consumer or other non hcp. A 64-year-old male patient received first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EW0162, expiration date unspecified), dose 1 via an unspecified route of administration on 26Apr2021 (at the age of 64-year-old) as 1st dose, single dose for COVID-19 immunization. Medical history included atypical pneumonia from an unknown date (twice as reported) and atypical flu from an unknown date. The patient's concomitant medications were not reported. On an unknown date in Apr2021, post vaccination the patient had the typical left arm soreness for about a day or two and then nothing. On an unknown date in May2021, (third week before getting his 2nd dose) the patient had muscle stiffness and soreness that was around his buttocks and his thighs. On 18May2021, the patient reported that his neck pops and he has never had that happen before. He was really healthy for 64 years old and he had no medical or health issues and he worked out all the time. Then he got the 2nd dose and within a day or two he was sore The outcome of the events was reported as unknown at time of report.  Information on Lot/Batch number was available. Additional information has been requested.
Breakthrough case admission after five vaccines  Pfizer 1/28/21 Lot# EL9261;  Pfizer 2/25/21 Lot# EN6202;  Pfizer 9/27/21 Lot# FC3183;  Pfizer 4/1/22 Lot# FK9895;  Pfizer 9/23/22 Lot# GH9702
03/16: Vaccine 03/18: Develop small cough 03/19: Voice is really bad, coughing (not dry) 03/20: Severe fatigue, voice is better 03/21: Severe fatigue, possible fever 03/22: Fighting fevers, lack of appetite  03/23: Fighting fevers, lack of appetite
Left arm at deltoid area swollen and warm to the touch, the day after the vaccine this occurred. Ice and Tylenol to the patient per mom.
pt recvd vax 22JUN92 & approx 10 days following vax devel diarrhea which became bloody diarrhea; pt noted to have intermittent frequent stools for 2-3 days since the loose bowel movement began; lab eval revealed WBC count 11,500 w/no diff
breakthrough covid - Tachycardia, tachypnea and respiratory failure - covid pneumonia
immediate vasovagal seeming response; dizziness, nausea, headache.  Then started with rigors.  Gave gatorade.  BP was systolic 94 (drop from 100 at start of visit prior to vaccination).  Rigors continued and after first denying any throat changes reported feeling a sore throat and numbness in her cheeks and all extremities.  Hyperventilation noted but O2 sat stable and normal at 99-100 but began posturing and tensing up.  Ambulance called and transport to local ER.
3 days after receiving  the vaccine was in pain and whole body became stiff, couldn't walk or sit.  Was diagnosed with Polymyalgia by doctor. Was prescribed prednisone.  Started off prednisone 40mg, currently down to 2mg as of 07/01/2021.
pt's mom contacted PHN informing provider that pt was evaluated @ ER last evening for leg swelling;was told had cellulitis & was rx cephalexin;has f/u appt tomorrow w/MD
Site: Itching at Injection Site-Mild, Additional Details: Patient felt slight itchy feeling around injection, (no redness or other visual changes) resolved within few min, patient observed for 30 min, followed up again with patietn 3 hours after at home, patient indicated no symptoms of itych or any other sensation, safe at home without complications
Patient noticed pain & difficulty moving L arm, then noticed a great deal of swelling, later had a severe HA. Swelling diminished with rest, HA mostly gone by next day. On 6/10/10 at clinic L upper arm with firm induration about 3x3 cm at medial deltoid, soft swelling from lower edge of deltoid to 2cm above elbow, from mid deltoid line to axillary line. Erythema over soft swelling. Neurovascular check intact.
Breakthrough case admission after 2 vaccines Moderna 3/27/21 Lot# 018B21A;  Moderna 4/24/21 lot# 043B21A
This spontaneous report as received from licensed practical nurse refers to a currently 19 year old female patient with no drug reactions/allergies. The patient's pertinent medical history included menorrhagia. At the age of 18 months old, approximately in August 1996, the patient was vaccinated with M-M-R II INJ, (dose, route and lot number not provided). Concomitant therapy included GILDESS FE (reported as GILDESS). On an unknown date, after receiving M-M-R II, the patient developed "multiple" seizures. The patient sought medical attention by an unspecified way. At the time of the report, the outcome of the event was unknown. Upon internal review, the event "The patient developed multiple seizures" was considered as medically significant. Additional information has been requested.
Patient presented to ED on 3/15/2021 with fatigue, subjective fevers, dry cough, and diarrhea found to have COVID pneumonia. CT PE negative at that time. Hospitalization complicated by RUE superficial cephalic vein thrombus, epistaxis, GIB, gluteal abscess, and AKI. Patient made DNR. Suspected cause of death: ventricular tachycardia secondary to renal failure and metabolic abnormalities in the setting of COVID ARDS.
KNOT WHERE SHOT WAS GIVEN AND SOME SWELLING AROUND SHOT A FEW .
11/06/2009 at 4:00 PM child notifed mother of rash between shoulder blades.  That evening the rash progressed to her chest.  On 11/08/2009 the rash progressed to underneath arms and down sides of torso.  That same day at 1:00 PM rash started up neck.  Mother describes rash as fine papular rash with itching.  Sores are not open.  Rash gets worse when she gets hot.  No fever.
He felt very weak and dizzy; He felt very weak and dizzy; I couldn't get out of the bed, I was struggling; Drowsiness; felt like a drunk; First dose administered 08Feb2021, second dose administered 17Feb2021; This is a spontaneous report from a contactable consumer (patient). A 76-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9266, Expiration date: Unknown), via an unspecified route of administration, administered in left arm on 17Feb2021 as dose 2, single for covid-19 immunisation in pop up clinic. No prior vaccinations were given within 4 weeks and no other vaccinations was given within four weeks prior to the first administration date of the suspect vaccine. Medical history included allergy to penicillin. The patient's concomitant medications were not reported. The patient previously took indocin [indometacin] and experienced hypersensitivity. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9264, Expiration date: Unknown), via an unspecified route of administration, administered in left arm on 08Feb2021 as dose 1, single for covid-19 immunisation. The patient was administered with first dose on 08feb2021, second dose administered on 17feb2021 and experienced he felt very weak and dizzy, he couldn't get out of the bed, he was struggling, felt like a drunk and drowsiness on 18Feb2021. The events did not result in emergency room or physician office. Patient received the second dose of the Pfizer-BioNtech Covid-19 vaccine on 17feb2021, next morning he felt very weak and dizzy, this symptom disappeared 15 hours later, patient stated he felt like a drunk. He would like to know if this could be related to the vaccine. The outcome of the event felt like a drunk was unknown and recovered for other events on 18Feb2021.  No follow-up attempts are possible. No further information is expected.
Information has been received from a physician concerning a 17 year old male who was vaccinated with a single dose of VAQTA. Concomitant vaccines administered the same day included MENACTRA. The patient developed a high fever of 104 degrees fahrenheit and was hospitalized for an unspecified amount of time after receiving a dose of VAQTA. The event was considered to be a significant disability. Subsequently, the patient recovered. No product quality complaint was involved. The event was considered to be immediately life-threatening and an other important medical event by the reporter. Additional information has been requested.
Acute bilateral pulmonary emboli - onset of shortness of breath 1 day prior to diagnosis on 6/14/2021
This spontaneous report was received from a registered nurse regarding a 22 Months old patient unknown gender. The patients' medical history, drug reactions/allergies and concomitant medications were not provided. On unknown dates, the patient was vaccinated with improperly stored doses of M-M-R II  lot # N013868, expiration date 04-MAY-2019 for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent (manufacturer unknown). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 9 to 25 (8.6) degrees Celsius for 16 minutes. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1805USA000142:
Numb fingers in left hand began on 10/15--started with fingertips, spread to entire hard to wrist. As of reporting date (10/20) numbness still present.
Erythema, swelling, hardness, pain, pruritis. area about 3" by 2".
spotting; This spontaneous case was reported by a consumer and describes the occurrence of VAGINAL HAEMORRHAGE (spotting) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood disorder.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced VAGINAL HAEMORRHAGE (spotting). On 19-Mar-2021, VAGINAL HAEMORRHAGE (spotting) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       she had some spotting after her vaccine which she described as blood in her panties.   Reporter did not allow further contact
Within a couple minutes after the shot, patient fainted for a few minutes then he came back on his own. I can see the patient was pale, confused, sweating, nausea.  I checked blood pressure and found that his BP was elevated 153/120 and pulse was 120. We did not give any medicines or epipen but just cold water. After 30 minutes of observation, i checked the BP again and it dropped back to 129/79, pulse was 70. Patient felt normal and was able to eat, drink and parent of patient decided to leave. Parent was advised to contact PCP for follow up.
92 yo female who received her first dose of Moderna vaccine on 1/11/2021 with no known adverse effects.  Admitted to the hospital on 1/17/21 with a spine compression fracture. Discharged and readmitted on 1/19 /21 with nausea and vomiting. Found to have new atrial flutter and elevated troponin attributed to NSTEMI.  Discharge on Aspirin and Plavix.  No cath.  Second dose of Moderna vaccine 2/25/21.  No immediate reaction.  One hour later began to feel progressively weak.  EMS called shortly after getting home.  Intubated in the field.  Died at 0658 on 2/26/21 s/p PEA arrest without ROSC.
Nausea; Body aches; Chills; Cough; Headache; Nasal congestion; Sinus pressure; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 10:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19. The patient was allergic to penicillin and sulfa based drugs. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included ethinylestradiol/levonorgestrel (ORSYTHIA) taken for birth control from an unknown date and unknown if ongoing. The patient previously received amoxicillin (MANUFACTURER UNKNOWN), cephalexin (MANUFACTURER UNKNOWN) and prednisone (MANUFACTURER UNKNOWN) and experienced drug allergy. On 21Apr2021 at 12:00, the patient experienced nausea, body aches, chills, cough, headache, nasal congestion, sinus pressure and tiredness. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events nausea, body aches, chills, cough, headache, nasal congestion, sinus pressure and tiredness was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Symptoms were subtle but peaked around mid-October.  Diagnosis was made the last week of October and treatment (methimazole and propranolol) was started.
mother reported on 8/2/99 that on 5/21/99 pt had sz; pt was taken to hosp, pt returned for vax w/hosp recommendation to give DT in place of DTAP; pt to go back to hosp next month; started on phenobarbital bid;
Pt received vaccine thru local health department on 02/26/2021. Pt developed the itching a few days after the injection and then the day after she developed swelling to right arm, warmth to right arm as well as redness which extends to her elbow. Pt continues with itching.
Information has been received from physician concerning a 4 year old female with no medical history and no allergies who on 17-JAN-2003 was vaccinated SC with a 0.5ml dose of Varivax (lot "1326M"). Concomitant therapy included a dose of MMR II and a dose of poliovirus vaccine. There were no other concomitant medications. In November 2005, the patient experienced breakthrough. No labs were done. At the time of this report the patient was recovering. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Vomiting  Sweats Chills Diarrhea  Very weak Times of delusion  Not able to eat for days It started Thursday evening and I did not feel where I could get up and around until Wednesday morning
Post vax, the patient's left thigh developed redness, local reaction, and was warm to the touch.
Raised rash, similar in appearance to measles, covering trunk of body. Does not itch. Rash has become less pronounced but is still present. It did not flare up with second dose of Moderna Lot # 036A21A given 03/03/2021.
Got my first Shingrix vaccine four years ago / my second one two months ago; This case was reported by a consumer via interactive digital media and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose of Shingrix vaccine 4 years ago from reporting date).   In October 2021, the patient received the 2nd dose of Shingrix. In October 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The patient received 2nd dose of Shingrix 2 months ago from the date of reporting, later than the recommended time interval, which led to lengthening of vaccination schedule. The reporter asked, if needed 3rd dose of Shingrix. The follow-up would not possible as no contact details were available.
Administration error: Vaccinator: paramedic, diluted 5-11 year Pfizer with 1.8mL of saline instead of 1.3mL and administered 0.3mL intramuscular deltoid.
I started itching on my limbs approximately 2 hours post injection. This moved to my trunk about 30 min after that. I had several raised red spots at this time. I took OTC Pepcid initially and at bedtime I took 2 benedryls. This relieved all symptoms.
Information has been received from the Merck pregnancy registry via a nurse concerning a 16 year old female who was vaccinated into the buttock with a dose of Gardasil at six weeks of gestation. Concomitant therapy included prenatal vitamins. The last menstrual period was 14-FEB-2007. Estimated date of delivery was 21-NOV-2007. On 12-SEP-2007 the patient reported that she was given the vaccine in her buttock during a intake examination with the obstetrician. The patient was currently being monitored for a fetal abnormality (hydrocephalus). Unspecified medical attention was sought. At the time of the report the patient was thirty weeks plus two days into gestation. The nurse reported that the hydrocephalus is not related to Gardasil. Additional information has been requested.
DEVELOPED COVID19 (ONSET AND DETAILS UNKNOWN, LOST TO FOLLOWUP) AND DIED
After both vaccines given patient appeared pale and was vomiting when I entered room. Vomiting resolved after approximately 5-10 min. Vital signs normal. Patient was able to tolerate sprite and crackers. Monitored for 30 min and discharged home with mom.